Atsushi Yokoyama Selected Research

PF 00477736

1/2020

CEP131 Abrogates CHK1 Inhibitor-Induced Replication Defects and Is Associated with Unfavorable Outcome in Neuroblastoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Atsushi Yokoyama Research Topics

Disease

8	Neoplasms (Cancer) 01/2022 - 12/2011
3	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2013
3	Hypertension (High Blood Pressure) 01/2020 - 01/2017
3	Pituitary ACTH Hypersecretion 01/2018 - 01/2014
2	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2019
2	Retinoblastoma (Glioblastoma, Retinal) 01/2022 - 06/2008
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021 - 01/2020
2	Williams Syndrome (Williams-Beuren Syndrome) 10/2013 - 11/2009
2	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 06/2012 - 12/2011
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2022
1	Schaaf-Yang syndrome 01/2022
1	Prader-Willi Syndrome (Syndrome, Prader-Willi) 01/2022
1	Melanoma (Melanoma, Malignant) 01/2022
1	Pneumothorax 09/2021
1	Chest Pain (Chest Pains) 09/2021
1	Pulmonary Edema 09/2021
1	Dyspnea (Shortness of Breath) 09/2021
1	Diplopia (Double Vision) 09/2021
1	Hyperaldosteronism (Conn Syndrome) 01/2021
1	Adrenocortical Carcinoma 01/2020
1	Obesity 01/2020
1	Neuroblastoma 01/2020
1	Muscle Spasticity (Spastic) 01/2020
1	Cardiomyopathies (Cardiomyopathy) 11/2018
1	Glycogen Storage Disease Type II (Pompe's Disease) 11/2018
1	Kidney Diseases (Kidney Disease) 01/2018
1	Proteinuria 01/2018
1	Respiratory Insufficiency (Respiratory Failure) 11/2016
1	Intellectual Disability (Idiocy) 11/2016
1	Pneumonia (Pneumonitis) 11/2016
1	Bronchitis 11/2016
1	Superior Mesenteric Artery Syndrome 01/2016
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2016
1	Weight Gain 01/2016
1	Body Weight (Weight, Body) 01/2016
1	Hyperekplexia 04/2015
1	Pica (Geophagia) 03/2014
1	Menkes Kinky Hair Syndrome (Menkes Disease) 03/2014
1	Colonic Neoplasms (Colon Cancer) 01/2014
1	Muscular Atrophy (Muscle Atrophy) 01/2013
1	Thyroiditis 05/2012

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2008
3	AldosteroneIBA 01/2021 - 01/2017
3	Cytochrome P-450 CYP11B2 (CYP11B2)IBA 01/2021 - 01/2017
3	Messenger RNA (mRNA)IBA 01/2020 - 01/2015
3	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2017 - 01/2014
2	AntigensIBA 01/2022 - 01/2022
2	AndrogensIBA 11/2021 - 01/2013
2	SteroidsIBA 09/2021 - 09/2021
2	MineralsIBA 01/2021 - 01/2017
2	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 01/2017 - 01/2015
2	Transcription Factors (Transcription Factor)IBA 10/2013 - 11/2009
1	Long Noncoding RNAIBA 01/2022
1	Capecitabine (Xeloda)FDA Link 01/2022
1	Proton Pump InhibitorsIBA 01/2022
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022
1	Lamin Type A (Lamin A)IBA 01/2022
1	LaminsIBA 01/2022
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 01/2022
1	ChromatinIBA 01/2022
1	Androgen Receptors (Androgen Receptor)IBA 11/2021
1	CalciumIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	angiotensin I (1-7)IBA 01/2021
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2020
1	Steroid 11-beta-Hydroxylase (11 beta-Hydroxylase)IBA 01/2020
1	salicylhydroxamic acid (SHAM)IBA 01/2020
1	PF 00477736IBA 01/2020
1	ErbB Receptors (EGF Receptor)IBA 01/2019
1	Biological ProductsIBA 01/2019
1	Pharmaceutical PreparationsIBA 01/2019
1	Oncogene Proteins (Oncogene Protein)IBA 01/2019
1	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 01/2018
1	PPAR gammaIBA 01/2018
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2018
1	Therapeutic UsesIBA 01/2018
1	Rosiglitazone (Avandia)FDA Link 01/2018
1	Pioglitazone (Actos)FDA Link 01/2018
1	LuciferasesIBA 01/2017
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2017
1	EnzymesIBA 01/2017
1	Anticonvulsants (Antiepileptic Drugs)IBA 04/2015
1	HX 630IBA 01/2015
1	Retinoid X Receptors (Retinoid X Receptor)IBA 01/2015
1	Phenobarbital (Luminal)FDA Link 03/2014
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 03/2014
1	Superoxides (Superoxide)IBA 03/2014
1	CopperIBA 03/2014
1	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 03/2014
1	Acrolein (Aqualin)IBA 03/2014
1	Superoxide Dismutase-1IBA 03/2014
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2014

Therapy/Procedure

3	Therapeutics 11/2021 - 02/2011
1	Castration 11/2021
1	Chest Tubes (Chest Tube) 09/2021
1	Enzyme Replacement Therapy 11/2018
1	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 11/2016
1	Postural Drainage 11/2016
1	Enteral Nutrition (Feeding, Tube) 01/2016
1	Gastrostomy 01/2016